San Diego Startups Raise $287M in Third Quarter, and Top 10 Deals
OCTOBER 11, 2016
Venture Capital investments in San Diego startups fell by roughly a third during the three months that ended September 30, according to data released recently by Seattle-based PitchBook and the National Venture Capital Association. As Xconomy reported last week , third-quarter venture funding also slipped nationwide to $14.99
San Diego Innovation Economy Extended Gains in 2015: Connect Report
SEPTEMBER 15, 2016
That’s according to a report being released today by Connect, the local nonprofit group focused on technology and entrepreneurship.
Q2 VC Funding Soars in San Diego (After Revisions), and Top 10 Deals
JULY 17, 2016
But the San Diego data was off. million in 19 companies in San Diego. million invested in 23 San Diego companies.
Santa Barbara, San Diego Tops On Per-Capita Venture Capital
JULY 15, 2013
San Diego-Carlsbad-San Marcos was number 7, with $36.6M in deals and 3.3 San Jose-Sunnyvale-Santa Clara; 2. READ MORE>>.
Synthetic Genomics Creates Host Organism Optimized for Bio Industry
AUGUST 29, 2016
According to the company, the findings reported today set the stage for commercialization of Vmax cells for molecular cloning and protein expression.
Immunotherapy Clinical Tests Spur Hope, and Plenty of Headaches
SEPTEMBER 7, 2016
Aduro reported in May that more dropouts than expected scuttled the trial. Blinding many studies is futile, say clinicians.
Nervana’s $400M+ Buyout Reflects Key Tech Trend in Machine Learning
AUGUST 10, 2016
Nervana, which now has 48 employees, plans to remain in San Diego and operate under its own brand name.
BlackThorn Emerges With $40M, New Weapons Against Neuro Disorders
OCTOBER 20, 2016
Today they’re finally shedding a little light on what they’ve been up to. Today, BlackThorn is making its first formal announcement. It’s similar here.
San Diego Sees Strong Cybersecurity Growth As Firms Seek Talent
JUNE 23, 2016
San Diego’s cybersecurity workforce has grown by nearly 15 percent over the past two years, according to a study released today by the Cyber Center of Excellence, a nonprofit industry group created to boost cybersecurity jobs and technologies in the region. The center also asked the San Diego Regional Economic Development Corp.
All In One Place: A New Immuno-Oncology Trial Resource
OCTOBER 19, 2016
As reporters, we find that frustrating. The infections were turbo-charging the immune system. Perhaps you do, too.
San Diego, Irvine Tops For Engineering Job Demand, Says Report
MAY 21, 2013
Two, Southern California markets-- San Diego and Irvine --are among the top ares for engineering job demand, according to a report today.
IBM Watson Health Launches Imaging Effort for Cancer, Other Diseases
JUNE 22, 2016
That means doctors should be able to use Watson to read and digest health records, lab results, radiology reports, and relevant medical literature.
Despite Low Crop Prices, Corporate and VC Agtech Investments Soar
OCTOBER 27, 2016
The increase in dollars flowing to agtech comes despite commodity prices that are down 65 percent from their 2013 peak, the report says.
Duchenne Lessons: Advocates For Rare Spinal Disease Have Eyes on FDA
AUGUST 26, 2016
Heather and Jessica Tomko will tell you that they’re nothing alike. They’ve got different interests, different tastes in movies, television, and music.
Biogen Buys Ionis Spine Disease Drug For $75M, Eyes FDA Filing
AUGUST 1, 2016
Spinal muscular atrophy affects over 25,000 people in the U.S. and stops many of them from ever being able to walk.
Biotech Roundup: Hellos, Goodbyes, “Cures” Delays And Trial News
JULY 15, 2016
Our San Diego editor Bruce Bigelow penned a personal goodbye to entrepreneur Larry Bock, who died last week of pancreatic cancer at the age of 56. —South San Francisco-based Second Genome hired a new CEO and president. The week started on a reflective note. And perhaps most important, there was the U.S. Or not.
Sony Slashes Staff At San Diego Game Studio
SEPTEMBER 15, 2016
Sony has cut more than 50 employees in San Diego, at its Sony San Diego Studio , which develops videogames such as Kill Strain and MLB. According to reports , the layoffs are part of a wider cut in its videogaming operations which also included workers in London. READ MORE>>.
Third-Quarter Report Shows Slowdown in VC Activity, & Top 10 Deals
OCTOBER 5, 2016
Venture capital activity is gradually easing from last year’s peak, according to a new quarterly report put together by Seattle-based PitchBook and the National Venture Capital Association. deals (1,796 companies) during the third quarter that ended September 30, according to the inaugural “Venture Monitor” report released today.
Bio Roundup: FDA Says No, PCSK9 Value Fight, CRISPR Intrigue & More
AUGUST 19, 2016
The CRISPR news this week doesn’t need a metaphor; the drama that MIT Technology Review reported can stand alone. — MIT Technology Review reported this week that a graduate student in the lab of Feng Zhang, Broad Institute gene-editing star, had accused the Broad of misleading the U.S. Talk about sacrifice.
Bio Roundup: RIP Roger Tsien, Novartis CAR-T Wheel, Zika News & More
SEPTEMBER 2, 2016
Nobel Prize winner Roger Tsien, a UC San Diego chemist, passed away in Oregon this week. As the San Diego Union Tribune reported in 2013, Tsien (pictured) was also unafraid to shine the spotlight on what he considered suspect scientific approaches, even when espoused by legends like DNA co-discoverer James Watson.
Bio Roundup: Theranos Cuts, Alnylam Stops, Nobel Eats Its Own & More
OCTOBER 7, 2016
—The Institute for Clinical and Economic Review (ICER), whose drug-value analyses set the pharma industry’s teeth on edge , issued a new report on PD-1 inhibitors , part of the first wave of cancer immunotherapy drugs to be approved. In December we’ll gather in San Francisco to discuss the U.S. TOP STORIES.
Regulus Shares Crumble As FDA Halts Testing of Hepatitis C Drug
JUNE 27, 2016
Regulus reported that a second serious case of jaundice, or a yellowing of the skin and eyes, in a Phase 1 study of RG-101.
Biotech Roundup: Scangos’s Exit, Zafgen’s Shakeup, Jounce, Relypsa & More
JULY 22, 2016
—Bruce Bigelow profiled Dauntless Pharmaceuticals , a stealthy biotech company creator in San Diego forming single-drug startups. —San Francisco gene therapy startup Audentes Pharmaceuticals (NASDAQ: BOLD ) raised $75 million in an IPO , selling 5 million shares at $15 apiece, right in its projected range.
MEI Pharma Partners with Helsinn on Drug with Potential $464M Payoff
AUGUST 8, 2016
months in previously untreated elderly patients who received the drug.
Checkpoints In Lung Cancer, and Other Oncology News From Europe
OCTOBER 11, 2016
Kite recently reported that a larger group of NHL patients had a similar response to KTE-C19 after three months. LUNG CHECKS. percent to $49.72.
What Startups Can Do About Cyber Attacks
SEPTEMBER 16, 2016
These statistics belie the common notion that cybercriminals attack only big businesses. Good Cybersecurity Program Matters. Understand the Risks.
Two San Diego Sites Rank Tops In Rising Social Networking Interest
AUGUST 29, 2012
Image courtesy Bigstock. READ MORE>>. social networking analysis pinterest experian skillwho stocktwits ranking
Recruitment Goal In Obama Precision Med Study: 1M in 3 or 4 Years
JULY 6, 2016
center led by the Scripps Research Institute in San Diego will work on ways for those individuals to participate.
Pharma’s Productivity Problem: Finding More Blockbuster Drugs
AUGUST 16, 2016
recent Silicon Valley Bank report noted that large corporations have dramatically increased pre-clinical acquisitions in the last three years under the pressure of limited supply and competition from IPOs. The authors made the point that, given the size of companies today, a single garden-variety blockbuster hardly moves the needle.
Bio Roundup: Jenkins Gets Mad, Bernie Gets His Pen, CRISPR IPO & J-Lo
OCTOBER 21, 2016
The hikes were first reported earlier this month by Adam Feuerstein of The Street. —Xconomy reported Monday that Tom Daniel, Celgene’s (NASDAQ: CELG ) former president of research and early development, left the Summit, NJ, company over the summer to start Catalysis Advisors in San Diego. TOP STORIES.
Bio Roundup: Mylan Grilled, Duchenne Kids Thrilled, Zuck-Chan & More
SEPTEMBER 23, 2016
The first concrete step is $600 million to establish a “biohub” in San Francisco that will bring together researchers from Stanford University, and the University of California campuses in San Francisco and Berkeley. — Ben Fidler contributed to this report. —The Medicines Co. —Photo of the U.S.
Ostendo Raising Funds to Advance Virtual Reality Display Technology
JULY 26, 2016
Adding to the confusion, the most-recent MoneyTree Report on San Diego venture capital activity shows that Ostendo raised almost $10 million in VC funding during the second quarter. Razi, Bussel, and Dull are also on the board of Ingenu, the San Diego wireless technology company known previously as On-Ramp Wireless.
Overcoming the Cybersecurity Skills Gap
SEPTEMBER 6, 2016
For example, does the team spend too much time pulling data and formatting reports, or managing IT tickets? Have a plan that expects to change.
Biotech Roundup: Fighting Addiction, Obama Precision, Juno Deaths & More
JULY 8, 2016
STAT was among the outlets to report that Gilead has also quietly raised prices on older HIV drugs, ostensibly to drive prescriptions toward newer alternatives. San Francisco’s Medivation (NASDAQ: MDVN ), co-owner of prostate cancer drug enzalutamide (Xtandi), remains biotech’s hottest target.
Bio Roundup: Precision Med and Google, Heron, Lilly, Sarepta & More
AUGUST 12, 2016
The wait continues. Will next week be the week a decision finally comes? Next month? Later today? Until then everyone sits, waits, and speculates.
Biotech Roundup: Biogen Rumors, Theranos, Electro-Drugs & More
AUGUST 5, 2016
The Wall Street Journal reported that Cambridge, MA-based Biogen (NASDAQ: BIIB ) has drawn interest from the likes of Merck (NYSE: MRK ) and Allergan (NYSE: AGN ) as a possible takeover target. —Meanwhile, scientists from San Diego-based Synthetic Genomics and the J. Bigelow contributed to this report.
Websense, After Move From San Diego, In Acquisition Talks
MARCH 17, 2015
Former San Diego-based security software developer Websense > --one of a number of companies acquired by private equity investor Vista Equity Partners and moved out of San Diego--is now in talks to be acquired by Raytheon , according to a report. Websense was acquired by Vista Equity Partners in 2013. READ MORE>>.
Biotech Roundup: Kadmon Debt, Hemo Data, Loose Lips & More
JUNE 17, 2016
The filing held some surprises , however, as Xconomy reported: plans to convert about $200 million in debt—a massive amount for a privately held biotech—into shares at the IPO, with some of those shares holding special privileges for their owners. —Ben Fidler contributed to this report. right now.
Biotech Roundup: CRISPR’s 3rd IPO, Gender Diversity, Buyouts & More
SEPTEMBER 16, 2016
— Bezinga first reported this week that Ron Farkas, head of the FDA team that reviewed the Duchenne muscular dystrophy drug eteplirsen from Sarepta Therapeutics (NASDAQ: SRPT ), recently left the agency. Alex Lash contributed to this report. Let’s get right to it. The drug is currently under FDA review. Shaw Research.
New Leader at Intel Capital Adjusts Strategy as Global Summit Opens
OCTOBER 24, 2016
The recent funding deals that Intel Capital laid out in San Diego Monday, on the first day of its 17th annual global summit, also reflect the strategic thinking of Wendell Brooks, who took the helm at Intel Capital about a year ago as longtime president Arvind Sodhani retired.